Psilocybin mushrooms, akin to LSD in their action as a serotonin 5-HT2A receptor agonist, are traditional psychedelics. Current research is focusing on the application of psilocybin in therapy for various mental health conditions. These include the emotional distress linked to major depression, anxiety, cluster headaches, and migraines.
In order to understand how shrooms can potentially alleviate these conditions, it’s essential to explore their metabolic process in the body. This knowledge enables both researchers and users to discern how the active compound exerts psychological and therapeutic effects. This article offers a basic overview of the pharmacology and pharmacokinetics of psilocybin.
[toc]
Key Takeaways:
- Half of the psychedelic fungi ingested orally is absorbed and dispersed throughout the body.
- The compound from the fungi is dephosphorylated by the enzyme alkaline phosphatase, primarily in the liver.
- Approximately 3.4% of the compound is expelled in its original form within 24 hours, with most of it being excreted as a stable metabolite.
What is Pharmacokinetics?
Pharmacokinetics (PK) refers to the study of how substances like drugs are processed by the body after they’re introduced into the system. It’s closely related to, yet distinct from, pharmacodynamics, which investigates how a compound interacts with the body. PK primarily concentrates on four aspects: absorption, distribution, metabolism, and excretion (ADME).
Grasping these processes enables medical practitioners to prescribe the most suitable medications with the least risk. It also allows them to customize treatments based on a patient’s unique physiology and lifestyle.
How Does Pharmacokinetics Relate to Psilocybin?
Psilocybin and psilocin, the predominant active compounds in some species of magic mushrooms, have garnered significant attention from both researchers and users. Pharmacokinetics seeks to understand how the body manages mushrooms containing psilocybin, helping to comprehend their potential effects, whether for medicinal or recreational purposes.
These compounds, often referred to as “magic,” “psychedelic,” “medicinal,” or “sacred,” are found in fungi that are ingested. The Mushroom species, their origin, size, the conditions required for their growth and drying process, and their age can all cause significant variations in their potency levels.
Mushrooms with these properties naturally exist in the wild, but scientists have also found ways to synthesize them in labs. Both the natural and lab-made versions demonstrate low levels of toxicity, though they can cause minor side effects such as nausea and vomiting.
Despite these side effects, the compounds found in these mushrooms have demonstrated potential therapeutic benefits due to their safety and lack of addictive properties. These benefits have prompted researchers to explore their use in psychotherapy, particularly for treating anxiety and depression.
The 4 Phases of Pharmacokinetics
Psilocybin, the compound present in these mushrooms, is inactive in its initial state and acts as a prodrug, converting into its active form, psilocin. Enzymes such as alkaline phosphatase facilitate this conversion, enabling psilocin to be absorbed and distributed throughout the body, reaching various tissues. However, after oral ingestion, psilocybin cannot be detected in the circulatory system, feces, or urine.
Absorption
Absorption refers to the process by which the compound enters the bloodstream from the site of administration. It determines how quickly and effectively the compound reaches its target area, such as the plasma. The compound is most commonly administered orally. Although inhalation has been tried, it proves less effective than oral intake.
The absorption process also involves the release of the compound from the dosage form during oral ingestion. Factors like delays in the throat or esophagus can affect this, potentially reducing the speed of absorption or causing irritation. Once the compound reaches the stomach, the acidic environment may start to break it down before it enters the bloodstream.
Studies on animals suggest that only about 50% of orally administered psychedelics are absorbed and distributed throughout the body.
Factors Influencing Absorption
Several factors can influence the absorption process, leading to variations in the onset, intensity, and duration of effects:
- Stomach Contents: Eating before ingesting can delay absorption as it slows the onset of effects. Absorption is typically faster on an empty stomach.
- Body Fat: Compounds have the ability to accumulate in fatty tissues, potentially prolonging their effects.
- Age: Metabolic rates and body composition can change with age.
- Zero-Order Kinetics: The substance is eliminated at a constant rate, regardless of its concentration.
- First-Order Kinetics: The elimination rate is relative to the drug’s concentration.
The concept of distribution deals with how psilocin disseminates within the body once it has entered the bloodstream. Psilocin, being lipophilic, has the capability to cross the blood-brain barrier and access the central nervous system.
Several factors determine this distribution process such as the size, polarity, and protein-binding capability of the substance, as well as the individual’s physiological conditions like hydration status and body composition.
The goal is to achieve an effective concentration at the targeted area. To ensure effectiveness, the substance should reach the intended location, as indicated by the volume of distribution, and remain unattached to proteins. This allows it to engage actively with its receptor.
What Factors Influence the Distribution Process?
Several factors can impact the distribution process:
The onset of effects typically begins within 20-40 minutes after ingestion, reaching its peak around 80-100 minutes. The effects of magic mushrooms generally last between 4-6 hours.
How is Distribution to the Brain Achieved?
An initial experimental study on two species demonstrated that its binding affinity sequence is 5HT2A > 5HT1A > 5HT2B [23]. It also interacts with dopamine D1, 5HT1E, 5HT5A, 5HT7, 5HT6, D3, 5HT2C, and 5HT1B receptors.
Psilocin acts as a partial agonist at the 5HT2A receptor, with an efficacy of roughly 40%. The psychedelic effects can be linked to its partial agonist activity at 5HT1A autoreceptors.
The mood-lifting and psychotomimetic experiences may be associated with the noticed relationship between increased dopamine levels and sensations of depersonalization and euphoria. Hallucinogens work by modifying neurochemistry and receptor functionality. They enhance 5HT2A agonist activity by boosting BDNF synthesis in the hippocampus, which subsequently encourages neurogenesis and reduces conditioned fear-related behaviors.
Elimination
Elimination refers to the method by which the
The human body expels substances through various routes, including the kidneys, lungs, skin, and the gastrointestinal tract. In relation to the kidneys, a naturally occurring psychedelic drug undergoes filtration in the glomerulus or secretion in the tubules. Additional reabsorption adds a layer of complexity to the process.
The primary compound has a half-life of about 160 minutes, while psilocin’s half-life is roughly 50 minutes. According to animal studies, the majority of this substance is removed through urination, accounting for around 65% within 8 hours. Even after consumption, small amounts of the compound can be detected in bile and feces.
In humans, roughly 3.4% of the substance is excreted in its original form within 24 hours, with a significant portion removed as psilocin-O-glucuronide, a more stable metabolite. This stability allows for the compound’s detection in urine tests over an extended duration.
There are two chief modes of substance excretion:
Most psychedelic drugs adhere to the first-order kinetics method, reaching stable concentrations after approximately four to five half-lives. Complete elimination also occurs after about four to five half-lives.
Discover Our Range of Psychedelic Mushrooms
The metabolic process can vary across different types of fungi. By choosing to buy from reliable online suppliers like Magic Mushrooms Montreal Canada, you can prevent accidental ingestion of harmful mushrooms. Some varieties, like Agaric mushrooms, can induce potent and undesirable effects. Hence, it’s critical to purchase magic mushrooms from trusted sources, rather than unverified street vendors or wild foraging.
| Feature | Enigma | Full Moon Party | Gold Member | |
| Strain Type | Psilocybe Cubensis OMNI | Psilocybe cubensis (Thai Koh Samui) | Psilocybe cubensis | |
| Potency | Exceptionally high; 3.8% tryptamine content | Moderate to high potency | High potency | |
| Visual Characteristics | Resembles a blob or | Resembling a cauliflower or brain in structure | Exhibits traditional Cubensis characteristics; of moderate size | Thick, white stems; caps in golden caramel color; visible blue bruising |
| Effects | Considered the most potent; induces intense effects | Powerful mental high; delayed onset followed by vivid visuals | Intense visual experiences and euphoria |
Educate Yourself on Psilocybin Mushroom Use Online
It’s crucial for medical professionals, researchers, and users to understand the pharmacokinetics of magic mushrooms. Such knowledge allows for informed decisions regarding dosage and timing, thus reducing potential risks.
Discover your perfect psychedelic experience at Magic Mushrooms Montreal Canada. Whether you desire a soothing journey or a deeper exploration, we offer a wide array of products to meet your specific requirements. Enjoy top-quality, safe, and regulated shrooms, eliminating worries about unreliable sources or poisonous mushrooms.
Sample the best magic mushrooms Canada has to offer and take your psychedelic journey to new heights.
Frequently Asked Questions
Are there any known interactions between magic mushrooms and other medications?
Potential interactions can occur between our products and certain medications, particularly those affecting serotonin levels, such as SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) typically reduce the effects, unlike non-serotonergic antidepressants. This reduced effect can continue for up to three months after discontinuing the antidepressant.
Do all psychedelics operate on the same pathway as psilocybin?
No, each psychedelic substance has a unique structure that requires different metabolic processes to activate, and they attach to various receptors in the body. The mode of administration also affects the absorption of each psychedelic. While the basic processes of absorption, metabolism, and distribution are the same, the specific pathways and effects vary for each substance.
Does the form of the mushroom affect its pharmacokinetics?
Yes, the form (whether fresh, powdered, or dried) can influence the absorption rate. For example, powdered varieties might be absorbed faster than whole dried ones due to quicker dissolution.
Further Reading:
